We are live on ! Find out more
BPTH

Bio-Path Holdings Inc
BPTH

Delisted

BPTH was delisted on the 18th of February, 2025.

Back to rankings

43 hedge funds and large institutions have $28.1M invested in Bio-Path Holdings Inc in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

325% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 4

7% less funds holding

Funds holding: 46 → 43 (-3)

30% less capital invested

Capital invested by funds: $39.9M → $28.1M (-$11.8M)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
43
Holders Change
-3
Holders Change %
-6.52%
% of All Funds
1.15%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
4
Increased
17
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RJFSA
Raymond James Financial Services Advisors
Florida
+$3.14M
2
Northern Trust
Northern Trust
Illinois
+$1M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$976K
4
BFA
BlackRock Fund Advisors
California
+$462K
5
PAM
Panagora Asset Management
Massachusetts
+$173K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$2.68M
2
Creative Planning
Creative Planning
Kansas
-$2.49M
3
Renaissance Technologies
Renaissance Technologies
New York
-$340K
4
Citadel Advisors
Citadel Advisors
Florida
-$64K
5
VKH
Virtu KCG Holdings
New York
-$57.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
NFA
26
Nationwide Fund Advisors
Ohio
$73K – – –
AIG
27
American International Group
New York
$67K – – –
BA
28
BlackRock Advisors
Delaware
$67K +$12.8K +2 +20%
IIC
29
Ironwood Investment Counsel
Arizona
$63K +$70.6K +11 New
CS
30
Credit Suisse
Switzerland
$47K -$6.42K -1 -11%
Wells Fargo
31
Wells Fargo
California
$46K – – –
Goldman Sachs
32
Goldman Sachs
New York
$38K +$12.8K +2 +40%
VKH
33
Virtu KCG Holdings
New York
$30K -$57.8K -9 -64%
Principal Financial Group
34
Principal Financial Group
Iowa
$26K +$6.42K +1 +25%
Morgan Stanley
35
Morgan Stanley
New York
$23K +$25.7K +4 New
Legal & General Group
36
Legal & General Group
United Kingdom
$20K – – –
Deutsche Bank
37
Deutsche Bank
Germany
$19K – – –
Citigroup
38
Citigroup
New York
$10K – – –
BNP Paribas Financial Markets
39
BNP Paribas Financial Markets
France
$8.4K +$6.42K +1 +100%
Bank of America
40
Bank of America
North Carolina
$5K +$6.42K +1 New
BlackRock
41
BlackRock
New York
$4K – – –
UBS Group
42
UBS Group
Switzerland
$2K – – –
Barclays
43
Barclays
United Kingdom
$1K – – –
TCM
44
Tradewinds Capital Management
Washington
$1K – – –
TCIM
45
TIAA CREF Investment Management
New York
$365 – – –
VOYA Investment Management
46
VOYA Investment Management
Georgia
$62 – – –
Renaissance Technologies
47
Renaissance Technologies
New York
– -$340K -43 Closed
Citadel Advisors
48
Citadel Advisors
Florida
– -$64K -8 Closed
ARTA
49
A.R.T. Advisors
New York
– -$30K -4 Closed
GCP
50
GSA Capital Partners
United Kingdom
– -$34K -4 Closed
1
2
3

BPTH Hedge Fund Activity: Q3 2016 in Review

43 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q3 2016, worth a combined $28.1M — down 30% from $39.9M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of BPTH and 4 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 17 added.

The largest buyer was Raymond James Financial Services Advisors, adding an estimated $3.14M. The largest seller was Sabby Management, cutting an estimated $2.68M.

  • 43 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q3 2016, down from 46 in Q2 2016.
  • Funds reported $28.1M of Bio-Path Holdings Inc stock for Q3 2016, down 30% quarter-over-quarter.
  • 4 funds opened new Bio-Path Holdings Inc positions in Q3 2016 and 7 closed out, a net change of -3 holders.
  • The largest Bio-Path Holdings Inc buyer in Q3 2016 was Raymond James Financial Services Advisors, an estimated $3.14M added.
  • The largest Bio-Path Holdings Inc seller in Q3 2016 was Sabby Management, an estimated $2.68M sold.

Based on aggregated 13F filings for Q3 2016.